annual CFO:
-$52.02M+$43.12M(+45.32%)Summary
- As of today (May 24, 2025), BCRX annual cash flow from operations is -$52.02 million, with the most recent change of +$43.12 million (+45.32%) on December 31, 2024.
- During the last 3 years, BCRX annual CFO has risen by +$90.14 million (+63.41%).
- BCRX annual CFO is now -1537.08% below its all-time high of -$3.18 million, reached on December 31, 2000.
Performance
BCRX Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$27.52M-$22.30M(-427.85%)Summary
- As of today (May 24, 2025), BCRX quarterly cash flow from operations is -$27.52 million, with the most recent change of -$22.30 million (-427.85%) on March 31, 2025.
- Over the past year, BCRX quarterly CFO has increased by +$26.17 million (+48.74%).
- BCRX quarterly CFO is now -204.44% below its all-time high of $26.35 million, reached on March 31, 2006.
Performance
BCRX quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$25.85M+$26.17M(+50.30%)Summary
- As of today (May 24, 2025), BCRX TTM cash flow from operations is -$25.85 million, with the most recent change of +$26.17 million (+50.30%) on March 31, 2025.
- Over the past year, BCRX TTM CFO has increased by +$75.46 million (+74.48%).
- BCRX TTM CFO is now -402.81% below its all-time high of $8.54 million, reached on March 31, 2006.
Performance
BCRX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
BCRX Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.3% | +48.7% | +74.5% |
| 3 y3 years | +63.4% | +64.6% | +83.7% |
| 5 y5 years | +41.9% | -18.2% | +69.9% |
BCRX Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +67.9% | -433.7% | +64.6% | at high | +84.8% |
| 5 y | 5-year | at high | +67.9% | -433.7% | +64.6% | at high | +85.0% |
| alltime | all time | -1537.1% | +67.9% | -204.4% | +64.6% | -402.8% | +85.0% |
BCRX Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$27.52M(+427.9%) | -$25.85M(-50.3%) |
| Dec 2024 | -$52.02M(-45.3%) | -$5.21M(-163.2%) | -$52.02M(-6.6%) |
| Sep 2024 | - | $8.24M(-702.7%) | -$55.73M(-33.6%) |
| Jun 2024 | - | -$1.37M(-97.5%) | -$83.87M(-17.2%) |
| Mar 2024 | - | -$53.68M(+502.0%) | -$101.31M(+6.5%) |
| Dec 2023 | -$95.14M(-41.2%) | -$8.92M(-55.2%) | -$95.14M(-13.6%) |
| Sep 2023 | - | -$19.90M(+5.8%) | -$110.07M(-10.2%) |
| Jun 2023 | - | -$18.81M(-60.4%) | -$122.62M(-6.8%) |
| Mar 2023 | - | -$47.51M(+99.2%) | -$131.56M(-18.7%) |
| Dec 2022 | -$161.85M(+13.9%) | -$23.85M(-26.5%) | -$161.85M(-5.1%) |
| Sep 2022 | - | -$32.44M(+16.9%) | -$170.46M(+5.7%) |
| Jun 2022 | - | -$27.76M(-64.3%) | -$161.29M(+1.5%) |
| Mar 2022 | - | -$77.80M(+139.7%) | -$158.95M(+11.8%) |
| Dec 2021 | -$142.16M(+5.2%) | -$32.46M(+39.5%) | -$142.16M(-6.6%) |
| Sep 2021 | - | -$23.28M(-8.4%) | -$152.23M(-9.0%) |
| Jun 2021 | - | -$25.41M(-58.4%) | -$167.21M(-3.3%) |
| Mar 2021 | - | -$61.01M(+43.5%) | -$172.84M(+27.9%) |
| Dec 2020 | -$135.11M(+50.8%) | -$42.53M(+11.2%) | -$135.11M(+31.1%) |
| Sep 2020 | - | -$38.26M(+23.2%) | -$103.03M(+11.5%) |
| Jun 2020 | - | -$31.04M(+33.3%) | -$92.41M(+7.6%) |
| Mar 2020 | - | -$23.28M(+122.8%) | -$85.87M(-4.1%) |
| Dec 2019 | -$89.58M(-3.2%) | -$10.45M(-62.2%) | -$89.58M(-13.1%) |
| Sep 2019 | - | -$27.64M(+12.8%) | -$103.12M(-6.7%) |
| Jun 2019 | - | -$24.50M(-9.2%) | -$110.52M(+10.6%) |
| Mar 2019 | - | -$27.00M(+12.6%) | -$99.91M(+7.9%) |
| Dec 2018 | -$92.56M(+125.0%) | -$23.98M(-31.5%) | -$92.56M(+17.0%) |
| Sep 2018 | - | -$35.03M(+152.1%) | -$79.10M(+40.0%) |
| Jun 2018 | - | -$13.89M(-29.3%) | -$56.50M(+8.1%) |
| Mar 2018 | - | -$19.65M(+86.8%) | -$52.27M(+27.0%) |
| Dec 2017 | -$41.14M(-23.0%) | -$10.52M(-15.4%) | -$41.14M(+12.8%) |
| Sep 2017 | - | -$12.43M(+28.6%) | -$36.48M(-12.3%) |
| Jun 2017 | - | -$9.67M(+13.4%) | -$41.61M(-3.5%) |
| Mar 2017 | - | -$8.53M(+45.7%) | -$43.12M(-19.3%) |
| Dec 2016 | -$53.44M(+307.4%) | -$5.85M(-66.7%) | -$53.44M(-14.4%) |
| Sep 2016 | - | -$17.56M(+57.0%) | -$62.41M(+8.5%) |
| Jun 2016 | - | -$11.18M(-40.6%) | -$57.51M(+103.7%) |
| Mar 2016 | - | -$18.84M(+27.1%) | -$28.23M(+115.2%) |
| Dec 2015 | -$13.12M(-66.0%) | -$14.83M(+17.1%) | -$13.12M(+7.7%) |
| Sep 2015 | - | -$12.66M(-170.0%) | -$12.18M(+50.0%) |
| Jun 2015 | - | $18.10M(-585.7%) | -$8.12M(-75.6%) |
| Mar 2015 | - | -$3.73M(-73.2%) | -$33.32M(-13.6%) |
| Dec 2014 | -$38.55M(+45.3%) | -$13.89M(+61.5%) | -$38.55M(+32.1%) |
| Sep 2014 | - | -$8.60M(+21.1%) | -$29.18M(+2.4%) |
| Jun 2014 | - | -$7.10M(-20.7%) | -$28.50M(+17.3%) |
| Mar 2014 | - | -$8.96M(+98.4%) | -$24.29M(-8.4%) |
| Dec 2013 | -$26.53M(-29.1%) | -$4.51M(-43.0%) | -$26.53M(-8.7%) |
| Sep 2013 | - | -$7.92M(+173.6%) | -$29.05M(-11.7%) |
| Jun 2013 | - | -$2.90M(-74.1%) | -$32.90M(-9.5%) |
| Mar 2013 | - | -$11.20M(+59.3%) | -$36.35M(-2.8%) |
| Dec 2012 | -$37.40M(+16.0%) | -$7.03M(-40.3%) | -$37.40M(+8.9%) |
| Sep 2012 | - | -$11.78M(+85.7%) | -$34.35M(+4.0%) |
| Jun 2012 | - | -$6.34M(-48.2%) | -$33.04M(+9.5%) |
| Mar 2012 | - | -$12.25M(+207.4%) | -$30.17M(-6.4%) |
| Dec 2011 | -$32.25M(+12.9%) | -$3.98M(-61.9%) | -$32.25M(-5.4%) |
| Sep 2011 | - | -$10.47M(+201.6%) | -$34.09M(+3.8%) |
| Jun 2011 | - | -$3.47M(-75.8%) | -$32.85M(-12.9%) |
| Mar 2011 | - | -$14.33M(+146.2%) | -$37.69M(+32.0%) |
| Dec 2010 | -$28.55M(+76.1%) | -$5.82M(-36.9%) | -$28.55M(+118.0%) |
| Sep 2010 | - | -$9.23M(+10.9%) | -$13.10M(+45.6%) |
| Jun 2010 | - | -$8.32M(+60.4%) | -$9.00M(-27.1%) |
| Mar 2010 | - | -$5.19M(-153.8%) | -$12.35M(-23.9%) |
| Dec 2009 | -$16.22M | $9.64M(-288.0%) | -$16.22M(-46.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$5.13M(-56.1%) | -$30.39M(-2.5%) |
| Jun 2009 | - | -$11.67M(+28.8%) | -$31.19M(+22.6%) |
| Mar 2009 | - | -$9.06M(+99.7%) | -$25.43M(+21.8%) |
| Dec 2008 | -$20.87M(-16.5%) | -$4.54M(-23.3%) | -$20.87M(-35.5%) |
| Sep 2008 | - | -$5.92M(+0.1%) | -$32.34M(+3.8%) |
| Jun 2008 | - | -$5.92M(+31.4%) | -$31.16M(+19.4%) |
| Mar 2008 | - | -$4.50M(-71.9%) | -$26.10M(+4.4%) |
| Dec 2007 | -$25.00M(+64.3%) | -$16.00M(+237.6%) | -$25.00M(+4.7%) |
| Sep 2007 | - | -$4.74M(+454.5%) | -$23.87M(-25.7%) |
| Jun 2007 | - | -$855.00K(-74.8%) | -$32.14M(-28.5%) |
| Mar 2007 | - | -$3.40M(-77.2%) | -$44.96M(+195.5%) |
| Dec 2006 | -$15.21M(-34.8%) | -$14.88M(+14.3%) | -$15.21M(+149.8%) |
| Sep 2006 | - | -$13.01M(-4.8%) | -$6.09M(-878.7%) |
| Jun 2006 | - | -$13.67M(-151.9%) | $781.80K(-90.8%) |
| Mar 2006 | - | $26.35M(-558.0%) | $8.54M(-136.6%) |
| Dec 2005 | -$23.35M(+28.6%) | -$5.75M(-6.3%) | -$23.35M(+1.5%) |
| Sep 2005 | - | -$6.14M(+3.8%) | -$23.01M(+11.0%) |
| Jun 2005 | - | -$5.92M(+6.8%) | -$20.73M(+6.5%) |
| Mar 2005 | - | -$5.54M(+2.2%) | -$19.47M(+7.3%) |
| Dec 2004 | -$18.15M(+62.1%) | -$5.42M(+40.2%) | -$18.15M(+17.6%) |
| Sep 2004 | - | -$3.86M(-16.9%) | -$15.44M(+5.7%) |
| Jun 2004 | - | -$4.65M(+10.3%) | -$14.61M(+14.5%) |
| Mar 2004 | - | -$4.22M(+55.9%) | -$12.76M(+14.0%) |
| Dec 2003 | -$11.20M(-31.6%) | -$2.71M(-10.6%) | -$11.20M(+4.2%) |
| Sep 2003 | - | -$3.03M(+8.0%) | -$10.74M(-3.0%) |
| Jun 2003 | - | -$2.81M(+5.6%) | -$11.08M(-14.7%) |
| Mar 2003 | - | -$2.66M(+18.1%) | -$12.98M(-20.7%) |
| Dec 2002 | -$16.36M(+61.1%) | -$2.25M(-33.1%) | -$16.36M(-5.9%) |
| Sep 2002 | - | -$3.36M(-28.6%) | -$17.39M(+7.3%) |
| Jun 2002 | - | -$4.71M(-22.0%) | -$16.21M(+16.1%) |
| Mar 2002 | - | -$6.04M(+84.1%) | -$13.97M(+37.5%) |
| Dec 2001 | -$10.16M(+219.7%) | -$3.28M(+50.3%) | -$10.16M(+17.3%) |
| Sep 2001 | - | -$2.18M(-11.4%) | -$8.66M(+0.5%) |
| Jun 2001 | - | -$2.46M(+10.4%) | -$8.61M(+11.4%) |
| Mar 2001 | - | -$2.23M(+25.4%) | -$7.74M(+143.4%) |
| Dec 2000 | -$3.18M(-35.2%) | -$1.78M(-16.8%) | -$3.18M(+87.1%) |
| Sep 2000 | - | -$2.14M(+35.0%) | -$1.70M(+2.4%) |
| Jun 2000 | - | -$1.58M(-168.1%) | -$1.66M(-6240.7%) |
| Mar 2000 | - | $2.33M(-875.7%) | $27.00K(-100.6%) |
| Dec 1999 | -$4.90M(+16.7%) | -$300.00K(-85.7%) | -$4.90M(+880.0%) |
| Sep 1999 | - | -$2.10M(-2200.0%) | -$500.00K(-58.3%) |
| Jun 1999 | - | $100.00K(-103.8%) | -$1.20M(-71.4%) |
| Mar 1999 | - | -$2.60M(-163.4%) | -$4.20M(0.0%) |
| Dec 1998 | -$4.20M(-59.2%) | $4.10M(-246.4%) | -$4.20M(-62.8%) |
| Sep 1998 | - | -$2.80M(-3.4%) | -$11.30M(+2.7%) |
| Jun 1998 | - | -$2.90M(+11.5%) | -$11.00M(+13.4%) |
| Mar 1998 | - | -$2.60M(-13.3%) | -$9.70M(-5.8%) |
| Dec 1997 | -$10.30M(+51.5%) | -$3.00M(+20.0%) | -$10.30M(+15.7%) |
| Sep 1997 | - | -$2.50M(+56.3%) | -$8.90M(+2.3%) |
| Jun 1997 | - | -$1.60M(-50.0%) | -$8.70M(+8.8%) |
| Mar 1997 | - | -$3.20M(+100.0%) | -$8.00M(+17.6%) |
| Dec 1996 | -$6.80M(-11.7%) | -$1.60M(-30.4%) | -$6.80M(0.0%) |
| Sep 1996 | - | -$2.30M(+155.6%) | -$6.80M(+7.9%) |
| Jun 1996 | - | -$900.00K(-55.0%) | -$6.30M(-4.5%) |
| Mar 1996 | - | -$2.00M(+25.0%) | -$6.60M(-14.3%) |
| Dec 1995 | -$7.70M(+18.5%) | -$1.60M(-11.1%) | -$7.70M(+1.3%) |
| Sep 1995 | - | -$1.80M(+50.0%) | -$7.60M(-1.3%) |
| Jun 1995 | - | -$1.20M(-61.3%) | -$7.70M(-2.5%) |
| Mar 1995 | - | -$3.10M(+106.7%) | -$7.90M(+21.5%) |
| Dec 1994 | -$6.50M | -$1.50M(-21.1%) | -$6.50M(+30.0%) |
| Sep 1994 | - | -$1.90M(+35.7%) | -$5.00M(+61.3%) |
| Jun 1994 | - | -$1.40M(-17.6%) | -$3.10M(+82.4%) |
| Mar 1994 | - | -$1.70M | -$1.70M |
FAQ
- What is BioCryst Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual CFO year-on-year change?
- What is BioCryst Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly CFO year-on-year change?
- What is BioCryst Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals TTM CFO year-on-year change?
What is BioCryst Pharmaceuticals annual cash flow from operations?
The current annual CFO of BCRX is -$52.02M
What is the all time high annual CFO for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual cash flow from operations is -$3.18M
What is BioCryst Pharmaceuticals annual CFO year-on-year change?
Over the past year, BCRX annual cash flow from operations has changed by +$43.12M (+45.32%)
What is BioCryst Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of BCRX is -$27.52M
What is the all time high quarterly CFO for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly cash flow from operations is $26.35M
What is BioCryst Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, BCRX quarterly cash flow from operations has changed by +$26.17M (+48.74%)
What is BioCryst Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of BCRX is -$25.85M
What is the all time high TTM CFO for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high TTM cash flow from operations is $8.54M
What is BioCryst Pharmaceuticals TTM CFO year-on-year change?
Over the past year, BCRX TTM cash flow from operations has changed by +$75.46M (+74.48%)